A new investigational delivery method for localized vaginal estrogen therapy that utilizes an applicator free softgel to alleviate moderate-to-severe vaginal pain during intercourse (dyspareunia), a ...

Please provide your email address to receive an email when new articles are posted on . Kingsberg and colleagues evaluated data from the phase 3 REJOICE trial on 764 postmenopausal women (mean age, 59 ...

*T max shown as median (range). More than two-thirds of women experience hot flashes during menopause, and approximately 25% of women during perimenopause and in the first years after menopause ...

Please provide your email address to receive an email when new articles are posted on . TherapeuticsMD recently received a Complete Response Letter from the FDA in reply to its New Drug Application ...

The FDA approval was supported by findings from a Phase 3, randomized, double-blind, placebo-controlled study that evaluated Imvexxy (4mcg and 10mcg) vs placebo from baseline to week 12. The Food and ...

Estrogens have widespread biologic actions, and there are naturally occurring phytoestrogens that mimic some of the actions of endogenously produced estrogens. In this review, we will focus on new ...

Elestrin™ (transdermal estradiol gel) is a new gel formulation of bioidentical estradiol developed by BioSante Pharmaceuticals, Inc. (IL, USA). In Elestrin, estradiol is carried in a patent-pending ...